Oral versus intravenous fluoropyrimidines for colorectal cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Versus Intravenous Fluoropyrimidines for Colorectal Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434871/all/Digoxin_for_preventing_or_treating_neonatal_respiratory_distress_syndrome:_Cochrane_systematic_review. Accessed 28 March 2024.
Oral versus intravenous fluoropyrimidines for colorectal cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434871/all/Digoxin_for_preventing_or_treating_neonatal_respiratory_distress_syndrome:_Cochrane_systematic_review. Accessed March 28, 2024.
Oral versus intravenous fluoropyrimidines for colorectal cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434871/all/Digoxin_for_preventing_or_treating_neonatal_respiratory_distress_syndrome:_Cochrane_systematic_review
Oral Versus Intravenous Fluoropyrimidines for Colorectal Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434871/all/Digoxin_for_preventing_or_treating_neonatal_respiratory_distress_syndrome:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral versus intravenous fluoropyrimidines for colorectal cancer
ID - 434871
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434871/all/Digoxin_for_preventing_or_treating_neonatal_respiratory_distress_syndrome:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -